Bridges Investment Management Inc. Grows Stock Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Bridges Investment Management Inc. increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 133.3% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 49,031 shares of the company's stock after buying an additional 28,019 shares during the quarter. Bridges Investment Management Inc.'s holdings in Option Care Health were worth $1,714,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. Murphy & Mullick Capital Management Corp bought a new position in Option Care Health during the 4th quarter worth about $26,000. Signaturefd LLC boosted its holdings in shares of Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock worth $28,000 after acquiring an additional 1,005 shares during the period. Bessemer Group Inc. raised its position in Option Care Health by 62.3% during the first quarter. Bessemer Group Inc. now owns 1,560 shares of the company's stock valued at $54,000 after purchasing an additional 599 shares in the last quarter. Quadrant Capital Group LLC raised its holdings in shares of Option Care Health by 172.8% during the 4th quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after buying an additional 1,099 shares in the last quarter. Finally, Public Employees Retirement System of Ohio grew its position in shares of Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company's stock valued at $43,000 after buying an additional 332 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Option Care Health Trading Down 1.5%

Shares of OPCH traded down $0.47 during trading hours on Friday, hitting $30.03. The company had a trading volume of 201,737 shares, compared to its average volume of 1,850,642. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. The stock's 50 day moving average price is $31.86 and its 200 day moving average price is $31.31. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm has a market cap of $4.92 billion, a P/E ratio of 24.21, a P/E/G ratio of 1.85 and a beta of 0.73.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. Option Care Health had a net margin of 4.12% and a return on equity of 16.90%. The company had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. During the same period in the previous year, the business earned $0.26 EPS. The firm's revenue for the quarter was up 16.3% on a year-over-year basis. On average, research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on OPCH. Barrington Research restated an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research report on Wednesday, June 18th. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and increased their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. One research analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $35.50.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.